Clinical trials
Terminated Hypertension trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
93 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 6 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 6 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 10 |
| 2018 | 6 |
| 2019 | 11 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 93 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brigham and Women's Hospital | 3 |
| University of California, San Francisco | 3 |
| University of Michigan | 3 |
| Federal University of Uberlandia | 2 |
| St George's, University of London | 2 |
| University of Colorado, Denver | 2 |
| University of Mississippi Medical Center | 2 |
| Abbott Medical Devices | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 93 |
| Diabetes Mellitus | 12 |
| Obesity | 9 |
| Cardiovascular Diseases | 6 |
| Hypercholesterolemia | 5 |
| Dyslipidemias | 4 |
| Essential Hypertension | 4 |
| Insulin Resistance | 4 |
| Renal Insufficiency, Chronic | 4 |
| Stroke | 4 |
Trials
Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.